Courtney Schiffman
Overview
Explore the profile of Courtney Schiffman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salvi A, Cluceru J, Gao S, Rabe C, Schiffman C, Yang Q, et al.
Ophthalmol Sci
. 2025 Jan;
5(2):100635.
PMID: 39758130
Purpose: The region of growth (ROG) of geographic atrophy (GA) throughout the macular area has an impact on visual outcomes. Here, we developed multiple deep learning models to predict the...
2.
Chang S, Jia G, Gao X, Schiffman C, Gupta S, Wolters P, et al.
Lung
. 2024 May;
202(3):269-273.
PMID: 38753183
Introduction: Pulmonary fibrosis is a characteristic of various interstitial lung diseases (ILDs) with differing etiologies. Clinical trials in progressive pulmonary fibrosis (PPF) enroll patients based on previously described clinical criteria...
3.
Richeldi L, Schiffman C, Behr J, Inoue Y, Corte T, Cottin V, et al.
Am J Respir Crit Care Med
. 2024 Feb;
209(9):1132-1140.
PMID: 38354066
A phase II trial reported clinical benefit over 28 weeks in patients with idiopathic pulmonary fibrosis (IPF) who received zinpentraxin alfa. To investigate the efficacy and safety of zinpentraxin alfa...
4.
Rebecca Sheng X, Gao X, Schiffman C, Jiang J, Ramalingam T, Lin C, et al.
Clin Immunol
. 2023 Jul;
254:109695.
PMID: 37479123
Drug development for systemic sclerosis (SSc) benefits from understanding the relationship between disease and circulating biomarkers to enable activities such as patient stratification and evaluation of therapeutic response. We measured...
5.
Maher T, Schiffman C, Kreuter M, Moor C, Nathan S, Axmann J, et al.
Respir Res
. 2022 Nov;
23(1):307.
PMID: 36369156
Background: Patients with interstitial lung disease (ILD) require regular physician visits and referral to specialist ILD clinics. Difficulties or delays in accessing care can limit opportunities to monitor disease trajectory...
6.
Petrick L, Imani P, Perttula K, Yano Y, Whitehead T, Metayer C, et al.
Leuk Res
. 2021 May;
106:106585.
PMID: 33971561
The etiology of pediatric acute myeloid leukemia (AML) is largely unknown, but evidence for mutations in utero and long latency periods suggests that environmental factors play a role. Therefore, we...
7.
Yano Y, Schiffman C, Grigoryan H, Hayes J, Edmands W, Petrick L, et al.
Leuk Res
. 2019 Nov;
88:106268.
PMID: 31760269
The developing fetus is exposed to chemicals, which are metabolized to electrophiles that form adducts with nucleophilic Cys34 of human serum albumin (HSA). By measuring these adducts in neonatal blood...
8.
Grigoryan H, Schiffman C, Gunter M, Naccarati A, Polidoro S, Dagnino S, et al.
Cancer Res
. 2019 Oct;
79(23):6024-6031.
PMID: 31641032
Chronic inflammation is an established risk factor for colorectal cancer. To study reactive products of gut inflammation and redox signaling on colorectal cancer development, we used untargeted adductomics to detect...
9.
Schiffman C, Petrick L, Perttula K, Yano Y, Carlsson H, Whitehead T, et al.
BMC Bioinformatics
. 2019 Jun;
20(1):334.
PMID: 31200644
Background: Untargeted metabolomics datasets contain large proportions of uninformative features that can impede subsequent statistical analysis such as biomarker discovery and metabolic pathway analysis. Thus, there is a need for...
10.
Petrick L, Schiffman C, Edmands W, Yano Y, Perttula K, Whitehead T, et al.
Cancer Lett
. 2019 Mar;
452:71-78.
PMID: 30904619
Early-life exposures are believed to influence the incidence of pediatric acute lymphoblastic leukemia (ALL). Archived neonatal blood spots (NBS), collected within the first days of life, offer a means to...